Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
Fiat Chrysler and France's Renault could soon partner up to take on the sweeping changes to the global auto industry, according to a report in the Financial Times. The...Autosread more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
The federal minimum wage has remained $7.25 per hour since 2009. But several states, and even some companies, have since taken matters into their own hands to pay employees a...Workread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
Cigna CEO David Cordani told CNBC on Wednesday he is "disappointed" activist investor Carl Icahn aired his concerns about the health insurer's acquisition of Express Scripts in an open letter instead of sharing them with Cigna.
Icahn published a searing letter Tuesday opposing Cigna's $54 billion acquisition of pharmacy benefit manager Express Scripts. Titled "Cigna's $60 billion folly," Icahn said buying the company "may well become one of the worst blunders in corporate history."
"We're disappointed that he chose that, his means of communication was an open letter," Cordani told CNBC's "Squawk on the Street." "There's been no inbound [communication] to our corporation."
Cigna says it and Express Scripts are complementary businesses that when combined can improve care for patients and lower health-care costs. Icahn argues looming regulatory risk combined with the possibility of Amazon disrupting the industry pose "existential threats to the PBM business model."
Pharmacy benefit managers control which drugs are covered and negotiate discounts, known as rebates, on branded drugs with manufacturers. They're a favorite target of drugmakers, who say these middlemen want higher drug prices so they can squeeze higher profits from rebates.
The Trump administration has vowed to re-examine this system. President Donald Trump spent a large chunk of his speech announcing his blueprint to lower drug prices attacking middlemen, who he said "won't be so rich anymore." Pfizer CEO Ian Read last week told Wall Street analysts he believes the Trump administration may eliminate rebates altogether.
Amazon does not currently operate in the prescription drug benefit space, though earlier this year it said it would acquire online pharmacy start-up PillPack.
"As it relates to Amazon, it's another example of change and evolution," Cordani said. "They're entering the mail order pharmaceutical fulfillment. We see that action, obviously we anticipated that action. The clinical integration, we think, is the point of differentiation."
Rival health insurer Aetna is in the process of being acquired by CVS Health. The roughly $69 billion deal would create a health-care powerhouse, combining insurance, prescription drug benefits and drugstores. Shareholders from both companies have already approved the deal, and CVS said Wednesday it expects it to close in the late third quarter or early fourth quarter.
"We're committed to this really attractive strategic and financial combination," Cordani said.